| Autor: |
Ingrid Belac Lovasić, Arnela Redžović, Dag Zahirović, Marija Petković |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Medicina fluminensis. 53:359-364 |
| ISSN: |
0025-7729 |
| Popis: |
Improvement in knowledge of molecular pathways of growth and developement of malignant kidney cancer has led to development of a number of efficient drugs. In this way the treatment of this condition nowadays is possible and successfull as documented by many clinical trials. New ways of treating kidney cancer tend to fulfill primary oncology goals which are to cure completely the patient or to make this serious disease a longlasting chronic disease. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
